Solventum Corporation logo
Solventum Corporation (SOLV)
Compare

SOLV Cash Flow Statement

Operating, investing, and financing cash flow analysis

SOLV Quarterly Cash Flow Statement (USD)

Quarterly ReportTTM
03/31/2026
12/31/2025
09/30/2025
06/30/2025
03/31/2025
12/31/2024
09/30/2024
06/30/2024
Cash from Operations (CFO)
151.000M-189.000M95.000M76.000M169.000M29.000M219.000M169.000M355.000M
1.432B13.000M63.000M1.266B90.000M137.000M31.000M122.000M89.000M
Depreciation & Amortization
758.000M135.000M380.000M121.000M122.000M129.000M150.000M133.000M133.000M
85.000M51.000M0.000.0034.000M49.000M25.000M27.000M56.000M
Change in Accounts Receivable
4.177B1.059B1.034B1.019B1.065B926.000M1.044B1.105B1.028B
Change in Inventory
Change in Accounts Payable
Change in Working Capital
-322.000M-360.000M-6.000M105.000M-61.000M-157.000M71.000M-87.000M98.000M
Cash from Investing
-354.000M-84.000M-63.000M-97.000M-110.000M-109.000M-127.000M-93.000M-58.000M
3.870B0.000.003.870B0.000.000.000.000.00
Cash from Financing
Debt Repayment
-67.000M-67.000M0.000.000.000.000.000.000.00
0.000.000.000.000.000.000.000.000.00
-203.000M-273.000M32.000M-21.000M59.000M-80.000M92.000M76.000M297.000M
Net Change in Cash
27.000M-317.000M-764.000M1.150B-42.000M-228.000M-10.000M-125.000M-99.000M

SOLV Annual Cash Flow Statement (USD)

Annual Report
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Cash from Operations (CFO)
369.000M1.185B1.915B1.679B2.202B2.026B
1.556B479.000M1.346B1.343B1.460B1.138B
Depreciation & Amortization
489.000M555.000M561.000M578.000M597.000M599.000M
161.000M112.000M39.000M37.000M38.000M35.000M
Change in Accounts Receivable
1.034B1.044B1.313B1.171B1.177B41.000M
Change in Inventory
Change in Accounts Payable
Change in Working Capital
-119.000M160.000M126.000M-202.000M67.000M234.000M
Cash from Investing
-379.000M-380.000M-290.000M-251.000M-277.000M-271.000M
-696.000M0.0060.000M0.000.000.00
Cash from Financing
Debt Repayment
0.000.000.000.000.000.00
0.000.000.000.000.000.00
-10.000M805.000M1.625B1.428B1.925B1.755B
Net Change in Cash
116.000M568.000M133.000M-30.000M-33.000M40.000M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About Solventum Corporation

Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.

Maplewood, MN
22,000 employees
Healthcare / Medical - Care Facilities
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Bryan C. Hanson